Axem Neurotechnology Inc.: federal grants and contributions: 18 agreements; $2.3M value; 2 departments; 7 programs.
Assay record ASY-CA-1IYG85V06H · Cite as: Assay Systems, “Axem Neurotechnology Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/axem-neurotechnology-inc/
Axem Neurotechnology is preparing to conduct pivotal clinical trials in 2023; this project entails work necessary for the use of those data for regulatory clearance (i.e., generating production equivalent version of the Axem Home headband), as well as work to de-risk those clinical trials with respect to their study endpoints, as well as with respect to the role of those data in procuring subsequent investment.
Axem Neurotechnology is building brain sensing headphones to assist athletes with quantifying — and improving — their mental practice and mental training, as well as to assist athletic and physical therapists with using imagery to enhance rehabilitation.
This project involves improving the technical performance of its headband prototype, by both re-designing its mechanical parts such that they can be repeatedly made to specification, and re-designing its electrical and mechanical parts such that the headband has its external temperature reduced during use. The project also involves work on the product's software, specifically developing algorithms that allow for real-time brain activity feedback through its tablet-based software, as well as algorithms and user-interface elements enabling motion-capture-based rehabilitation games (utilizing onl
Axem Neurotechnology is preparing to go to market with a digital health service facilitating at-home stroke recovery. The current project will enable Axem to enhance its in-house manufacturing capacities, refine its device to enable a more scalable business model, and also improve its ability to use data from its medical device to personalize post-stroke recovery.
Undertake quality assurance, safety certification and regulatory compliance
Conduct clinical trials on prototypes to demonstrate clinical value
Support for hiring a clinical data analyst and enhanced product development
Axem Neurotechnology is building the Axem Home—a home rehabilitation system that includes a portable brain-sensing device paired with training software.
Provide assistance to mitigate impacts of Covid-19
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small and medium-sized enterprises that are unable to access existing COVID-19 business support.
Engage expertise to help build a functional prototype
Engage technical expertise to improve upon an existing prototype
Engage consultants to build long term product and business strategy
Engage consultants for two clinical studies
The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
The project will support development of intellectual property capacity within the firm.
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.